Logo for Mirum Pharmaceuticals Inc

Mirum Pharmaceuticals Inc Investor Relations Material

Latest events

Logo for Mirum Pharmaceuticals Inc

Study Result

Mirum Pharmaceuticals Inc
Logo for Mirum Pharmaceuticals Inc

Study Result

17 Jun, 2024
Logo for Mirum Pharmaceuticals Inc

Q1 2024

8 May, 2024
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies

Latest reports from Mirum Pharmaceuticals Inc

Access all reports
Mirum Pharmaceuticals, Inc. is a biopharmaceutical company focused on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company was founded with the goal of developing drugs that can address unmet medical needs. It has developed two lead candidates. These two therapies are designed to treat patients suffering from rare genetic disorders that affect their metabolism, such as phenylketonuria (PKU).